# Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil

> **NCT00400647** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 136 (actual)

## Conditions studied

- Maintenance Kidney Transplant

## Interventions

- **DRUG:** Enteric-coated Mycophenolate sodium (EC-MPS)
- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT00400647
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00400647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00400647, "Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00400647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*